Dicerna Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 41.337 million compared to USD 40.448 million a year ago. Operating loss was USD 40.244 million compared to USD 33.493 million a year ago. Net loss was USD 40.815 million compared to USD 31.820 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.43 a year ago. For the half year, sales was USD 88.940 million compared to USD 74.476 million a year ago. Operating loss was USD 69.351 million compared to USD 58.659 million a year ago. Net loss was USD 70.780 million compared to USD 54.312 million a year ago. Basic loss per share from continuing operations was USD 0.92 compared to USD 0.74 a year ago.